Search Within

Neeta Pandit-Taskar

  1. "GSK Faculty"
Formats
  1. Meeting Abstract (74)
  2. Journal Article (69)
  3. Book Section (2)
Groups
  1. GSK Faculty (145)
  2. Molecular Imaging and Therapy Service (145)
  3. Radiology, Department of (145)
  4. Molecular Pharmacology and Chemistry Program Faculty (103)
  5. Sloan Kettering Institute Faculty (103)
  6. Medical Physics (83)

More Groups

People
  1. Steven Larson (99)
  2. Jorge Carrasquillo (61)
  3. Jason Lewis (52)
  4. Nai-Kong Cheung (48)
  5. Serge Lyashchenko (48)
  6. Pat Zanzonico (46)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (5)
  4. 2022 (10)
  5. 2021 (6)
  6. 2020 (5)

More Years

Publications
  1. Journal of Clinical Oncology (34)
  2. Journal of Nuclear Medicine (28)
  3. Neuro-Oncology (13)
  4. Pediatric Blood and Cancer (13)
  5. Clinical Cancer Research (11)
  6. European Journal of Nuclear Medicine and Molecular Imaging (8)

More Publications

Publishers
  1. American Society of Clinical Oncology (34)
  2. Society of Nuclear Medicine (28)
  3. Springer (20)
  4. American Association for Cancer Research (15)
  5. Oxford University Press (14)
  6. Wiley Periodicals, Inc (13)

More Publishers

Results (145)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase 1 dose-escalation trial using convection-enhanced delivery of radiolabeled monoclonal antibody for diffuse intrinsic pontine glioma following external radiation therapy
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Taskar, N.; Haque, S.; Zanzonico, P.; Carrasquillo, J. A.; Lyashchenko, S. K.; Thakur, S. B.; Khakoo, Y.; Donzelli, M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Early predictors of benefit to dual anti-PD1/HER2 inhibition: Biomarker analysis from phase 2 trial of pembrolizumab/trastuzumab in HER2-positive metastatic esophagogastric (mEG) cancer
    Meeting Abstract

    Maron, S. B.; Chatila, W. K.; Walch, H. S.; Ptashkin, R.; Sabwa, S.; Ling, L.; Nagy, R.; Simmons, M.; Do, R. K. G.; Paroder, V.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Imaging HER2-positive metastatic esophagogastric cancer with (89)Zr-trastuzumab PET and (18)F-FDG PET
    Meeting Abstract

    Lumish, M. A.; Maron, S. B.; Paroder, V.; Philemond, S.; O'Donoghue, J. A.; Schoder, H.; Lewis, J. S.; Janjigian, Y. Y.; Pandit-Taskar, N.
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals
    Journal Article

    Kalidindi, T. M.; Lee, S. G.; Jou, K.; Chakraborty, G.; Skafida, M.; Tagawa, S. T.; Bander, N. H.; Schoder, H.; Bodei, L.; Pandit-Taskar, N.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2021)

    Fulltext@MSK | Save
  • Imaging tumor-infiltrating lymphocytes in brain tumors with [(64)Cu]Cu-NOTA-anti-CD8 PET
    Journal Article

    Nagle, V. L.; Henry, K. E.; Hertz, C. A. J.; Graham, M. S.; Campos, C.; Parada, L. F.; Pandit-Taskar, N.; Schietinger, A.; Mellinghoff, I. K.; Lewis, J. S.
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • IntraOmmaya compartmental radioimmunotherapy using (131)I-omburtamab-pharmacokinetic modeling to optimize therapeutic index
    Journal Article

    Yerrabelli, R. S.; He, P.; Fung, E. K.; Kramer, K.; Zanzonico, P. B.; Humm, J. L.; Guo, H.; Pandit-Taskar, N.; Larson, S. M.; Cheung, N. K. V.
    European Journal of Nuclear Medicine and Molecular Imaging (2021)

    Fulltext@MSK | Save
  • B7H3-directed intraperitoneal radioimmunotherapy with radioiodinated omburtamab for desmoplastic small round cell tumor and other peritoneal tumors: Results of a phase I study
    Journal Article

    Modak, S.; Zanzonico, P.; Grkovski, M.; Slotkin, E. K.; Carrasquillo, J. A.; Lyashchenko, S. K.; Lewis, J. S.; Cheung, I. Y.; Heaton, T.; LaQuaglia, M. P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • High-dose naxitamab (humanized-3F8) plus stepped-up dosing of granulocyte-macrophage colony-stimulating factor (GM-CSF) for Resistant Osteomedullary Neuroblastoma: Major Responses and Outpatient Treatment in a Phase II Trial
    Meeting Abstract

    Kushner, B.; Modak, S.; Basu, E.; Roberts, S.; Mauguen, A.; Pandit-Taskar, N.; Cheung, N. K.
    Pediatric Blood and Cancer (2020)

    Fulltext@MSK | Save
  • Comparison of (68)Ga-DOTA-JR11 PET/CT with dosimetric (177)Lu-satoreotide tetraxetan ((177)Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapy
    Journal Article

    Krebs, S.; O'Donoghue, J. A.; Biegel, E.; Beattie, B. J.; Reidy, D.; Lyashchenko, S. K.; Lewis, J. S.; Bodei, L.; Weber, W. A.; Pandit-Taskar, N.
    European Journal of Nuclear Medicine and Molecular Imaging (2020)

    Fulltext@MSK | Save
  • Positron lymphography via intracervical (18)F-FDG injection for presurgical lymphatic mapping in cervical and endometrial malignancies
    Journal Article

    Mueller, J. J.; Dauer, L. T.; Murali, R.; Iasonos, A.; Pandit-Taskar, N.; Abu-Rustum, N. R.; Grimm, J.
    Journal of Nuclear Medicine (2020)

    Fulltext@MSK | Save